Humanized Monoclonal Antibody Fragment [EPC]

1286 reported adverse events

Drugs of this class: IDARUCIZUMAB

These side effects are most commonly reported by patients taking drugs of the Humanized Monoclonal Antibody Fragment [EPC] class:

# Side effect Count
0 DEATH 152
1 HAEMORRHAGE 95
2 GASTROINTESTINAL HAEMORRHAGE 75
3 CEREBRAL HAEMORRHAGE 72
4 HAEMORRHAGE INTRACRANIAL 66
5 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56
6 DRUG INEFFECTIVE 52
7 ISCHAEMIC STROKE 42
8 PNEUMONIA 39
9 ACUTE KIDNEY INJURY 38
See all common reactions for Humanized Monoclonal Antibody Fragment [EPC]

Drugs of the Humanized Monoclonal Antibody Fragment [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIMB GIRTH INCREASED 1 0.1250
1 COAGULATION FACTOR INCREASED 5 0.0926
2 DECOMPRESSIVE CRANIECTOMY 1 0.0769
3 THROMBIN TIME ABNORMAL 3 0.0732
4 ANTICOAGULATION DRUG LEVEL INCREASED 11 0.0437
5 PROCEDURAL SHOCK 1 0.0400
6 BASILAR ARTERY ANEURYSM 1 0.0400
7 BASILAR ARTERY OCCLUSION 5 0.0362
8 BASAL GANGLIA HAEMATOMA 1 0.0345
9 SPLEEN SCAN ABNORMAL 1 0.0345
See all enriched reactions for Humanized Monoclonal Antibody Fragment [EPC]